Mitchell & Pahl Private Wealth LLC Acquires 338 Shares of UnitedHealth Group Incorporated $UNH

Mitchell & Pahl Private Wealth LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% in the 2nd quarter, Holdings Channel.com reports. The fund owned 9,249 shares of the healthcare conglomerate’s stock after buying an additional 338 shares during the period. UnitedHealth Group makes up approximately 1.3% of Mitchell & Pahl Private Wealth LLC’s portfolio, making the stock its 19th largest position. Mitchell & Pahl Private Wealth LLC’s holdings in UnitedHealth Group were worth $2,885,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Compass Ion Advisors LLC grew its stake in shares of UnitedHealth Group by 59.2% in the second quarter. Compass Ion Advisors LLC now owns 1,121 shares of the healthcare conglomerate’s stock valued at $350,000 after buying an additional 417 shares in the last quarter. Coastwise Capital Group LLC grew its stake in shares of UnitedHealth Group by 63.4% in the second quarter. Coastwise Capital Group LLC now owns 1,335 shares of the healthcare conglomerate’s stock valued at $417,000 after buying an additional 518 shares in the last quarter. Grant Private Wealth Management Inc grew its stake in shares of UnitedHealth Group by 311.7% in the second quarter. Grant Private Wealth Management Inc now owns 5,538 shares of the healthcare conglomerate’s stock valued at $1,728,000 after buying an additional 4,193 shares in the last quarter. Wedge Capital Management L L P NC grew its stake in shares of UnitedHealth Group by 19.5% in the second quarter. Wedge Capital Management L L P NC now owns 24,459 shares of the healthcare conglomerate’s stock valued at $7,630,000 after buying an additional 3,998 shares in the last quarter. Finally, CX Institutional grew its stake in shares of UnitedHealth Group by 23.2% in the second quarter. CX Institutional now owns 20,405 shares of the healthcare conglomerate’s stock valued at $6,366,000 after buying an additional 3,840 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of several research reports. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. JPMorgan Chase & Co. cut their price target on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Oppenheimer cut their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Wells Fargo & Company cut their price target on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Finally, Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $336.72 on Friday. The stock has a market cap of $304.96 billion, a P/E ratio of 14.59, a price-to-earnings-growth ratio of 2.20 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock’s 50-day moving average is $295.67 and its 200-day moving average is $364.42. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.